Topic: Alzheimer’s

Two-year, full-time research appointment in David Berron’s Clinical Cognitive Neuroscience group, with possible extension. The project develops smartphone-based cognitive measures to detect and predict early Alzheimer’s-related memory decline. Work includes preparing clinical, cognitive, imaging and blood-biomarker datasets, analysing repeated measurements with regression and mixed-effects models, supporting data collection and collaborating across cohorts. The employer welcomes both postdoctoral and PhD-track applications.

Supports translational studies of potential Alzheimer’s and related-dementia therapies, including early human safety, target engagement and proof of mechanism. Awards provide up to USD 1 million over two to three years; selected Phase 3 or biomarker-validation proposals can also qualify. Letters of intent are due 20 October 2026 at 17:00 Eastern time (22 October for ISTAART members); invited full applications follow on 15 December (17 December for members).